Amdocs Ltd
NASDAQ:DOX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
74.9
93.57
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Amdocs Ltd
Wall Street
Price Targets
DOX Price Targets Summary
Amdocs Ltd
According to Wall Street analysts, the average 1-year price target for
DOX
is 104.16 USD
with a low forecast of 98.39 USD and a high forecast of 116.55 USD.
DOX Last Price Targets
Amdocs Ltd
The latest public price target was made on Nov 13, 2024 by
Shaul Eyal
from
Oppenheimer
,
who expects
DOX
stock to
rise by 21%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Shaul Eyal
Oppenheimer
|
105
USD
Upside 21% |
1 month ago
Nov 13, 2024
|
Amdocs Ltd. (DOX) PT Raised to $105 at Oppenheimer
StreetInsider
|
Tom Roderick
Stifel Nicolaus
|
100
USD
Upside 15% |
2 months ago
Oct 1, 2024
|
Stifel Starts Amdocs Ltd. (DOX) at Buy
StreetInsider
|
William Power
Robert W. Baird
|
90
USD
Upside 3% |
7 months ago
May 9, 2024
|
Amdocs Ltd. (DOX) PT Lowered to $90 at Baird
StreetInsider
|
|
Unknown Analyst
Oppenheimer
|
99
USD
Upside 14% |
1 year ago
Feb 1, 2023
|
Oppenheimer Maintains Outperform on Amdocs, Raises Price Target to $99
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DOX's stock price target?
Price Target
104.16
USD
According to Wall Street analysts, the average 1-year price target for
DOX
is 104.16 USD
with a low forecast of 98.39 USD and a high forecast of 116.55 USD.
What is Amdocs Ltd's Revenue forecast?
Projected CAGR
3%
For the last 8 years the
compound annual growth rate for
Amdocs Ltd's revenue is
4%.
The projected
CAGR
for the next 4 years is
3%.
What is Amdocs Ltd's Operating Income forecast?
Projected CAGR
12%
For the last 8 years the
compound annual growth rate for
Amdocs Ltd's operating income is
4%.
The projected
CAGR
for the next 3 years is
12%.
What is Amdocs Ltd's Net Income forecast?
Projected CAGR
15%
For the last 8 years the
compound annual growth rate for
Amdocs Ltd's net income is
2%.
The projected
CAGR
for the next 4 years is
15%.
You don't have any saved screeners yet
